Response of dairy cows to high doses of a sustained-release bovine somatotropin administered during two lactations. 2. Health and reproduction
- PMID: 1541726
- DOI: 10.3168/jds.s0022-0302(92)77745-5
Response of dairy cows to high doses of a sustained-release bovine somatotropin administered during two lactations. 2. Health and reproduction
Abstract
Eighty-two lactating Holstein cows in their first, second, or third lactation received either one, three, or five concurrent i.m. injections of a unit dose (.6 g) of zinc methionyl bST (sometribove) or five doses of the vehicle. Injections were given at 14-d intervals from 60 +/- 3 d postpartum until the end of lactation or necropsy. Thirty-eight animals were continued on treatment for a 2nd yr. Sometribove did not affect the incidence of ketosis, milk fever, tetany, or pneumonia. Digestive disorders, primarily cows going off feed, were increased by bST during yr 1 only. The incidence of lameness was increased by bST in some time frames because of an increase in the 3.0-g bST group. Lameness was not associated with treatment-specific histopathologic changes or with abnormalities in cartilage or bone. Reproductive health generally was unaffected by treatment, but delayed conception and increased incidence of abortion were noted. Incidence of cystic ovaries was unaffected by bST. Pregnancy rates were decreased during the 100-d breeding interval of yr 1 but not during the 215-d interval of yr 2. The incidence of clinical mastitis was increased by bST, primarily at the 3.0-g dose. During the 2-yr study, 0, 3, 3, and 2 cows died or became moribund on 0, .6, 1.8, and 3.0 g of bST, respectively. Health issues identified for further evaluation included lameness and clinical mastitis for the 3.0-g group and early removal from the herd and decreased reproductive performance for all bST groups. Bovine somatotropin caused no treatment-specific toxic effects in dairy cows even at 3.0 g every 14 d.
Similar articles
-
Response of dairy cows to high doses of a sustained-release bovine somatotropin administered during two lactations. 1. Production response.J Dairy Sci. 1991 Nov;74(11):3807-21. doi: 10.3168/jds.s0022-0302(91)78573-1. J Dairy Sci. 1991. PMID: 1757623
-
Effects of sustained release bovine somatotropin (sometribove) on animal health in commercial dairy herds.J Dairy Sci. 2001 May;84(5):1098-108. doi: 10.3168/jds.S0022-0302(01)74570-5. J Dairy Sci. 2001. PMID: 11384036 Clinical Trial.
-
Effect of high doses of a sustained-release bovine somatotropin on antibody formation in dairy cows.J Dairy Sci. 1992 Nov;75(11):2959-67. doi: 10.3168/jds.S0022-0302(92)78059-X. J Dairy Sci. 1992. PMID: 1460127 Clinical Trial.
-
Meta-analysis of the effects of sometribove zinc suspension on the production and health of lactating dairy cows.J Am Vet Med Assoc. 2014 Sep 1;245(5):550-64. doi: 10.2460/javma.245.5.550. J Am Vet Med Assoc. 2014. PMID: 25148097 Review.
-
Management of the dairy herd treated with bovine somatotropin.Vet Clin North Am Food Anim Pract. 1991 Jul;7(2):417-37. doi: 10.1016/s0749-0720(15)30795-7. Vet Clin North Am Food Anim Pract. 1991. PMID: 1893279 Review.
Cited by
-
Public health implications of bovine somatotropin use in dairying: discussion paper.J R Soc Med. 1992 Dec;85(12):736-9. doi: 10.1177/014107689208501209. J R Soc Med. 1992. PMID: 1494163 Free PMC article. No abstract available.
-
A meta-analysis review of the effects of recombinant bovine somatotropin. 2. Effects on animal health, reproductive performance, and culling.Can J Vet Res. 2003 Oct;67(4):252-64. Can J Vet Res. 2003. PMID: 14620861 Free PMC article. Review.
-
Effect of recombinant bovine somatotropin (rbST) treatment on follicular population and development in non-lactating dairy cows.Anim Reprod. 2019 Nov 18;16(4):914-922. doi: 10.21451/1984-3143-AR2018-0118. Anim Reprod. 2019. PMID: 32368271 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources